All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Study links dihydropyridine calcium channel blockers to worse kidney outcomes in type 2 diabetes patients

By

ByLucas Laboy

4d ago· 5 min readenNews
sciencehealthmedical researchnephrology

Summary

A study presented at the European Renal Association Congress found that dihydropyridine calcium channel blockers (DCCBs), a commonly prescribed antihypertensive medication, may be linked to worse kidney outcomes in patients with type 2 diabetes and diabetic kidney disease. Researchers led by Dr. Timna Agur from Rabin Medical Center in Israel analyzed data suggesting these medications could negatively impact kidney function in this patient population.

Source

Twitter / XStudy links dihydropyridine calcium channel blockers to worse kidney outcomes in type 2 diabetes patientshealio.com

Key quotes

· 2 pulled
Dihydropyridine calcium channel blockers (DCCBs) are a commonly prescribed antihypertensive medication for patients with diabetic kidney disease, according to Timna Agur, MD, senior nephrologist at Rabin Medical Center in Israel.
Agur and colleagues sought to understand what effect DCCBs, in con
Snippet from the RSS feed
Dihydropyridine calcium channel blockers may be linked to worse kidney outcomes for patients with type 2 diabetes, according to study data presented at the European Renal Association Congress in Glasgow, Scotland. Dihydropyridine calcium channel blockers

You might also wanna read

Mineralys' pill cuts blood pressure in kidney disease patients

reuters.com·1mo ago

Research Suggests Heart Disease, Kidney Disease and Type 2 Diabetes May Be One Condition Treatable with GLP-1 Drugs

The article discusses the emerging medical concept of "CKM syndrome" (cardiometabolic kidney syndrome), which suggests that heart disease, k

scientificamerican.com·6mo ago

STAT+: FDA approves Vera Therapeutics kidney disease treatment

STAT·2h ago

Researchers Reverse Kidney Damage in Mice by Targeting Ceramide-Induced Mitochondrial Damage

Researchers at University of Utah Health discovered that fatty molecules called ceramides trigger acute kidney injury (AKI) by damaging mito

sciencedaily.com·7mo ago

Gene–disease relationships for glomerular phenotypes: expert recommendations from ClinGen

doi.org·13d ago

Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us

doi.org·11d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.